Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as made
This instrument amends the Health Insurance (Section 3C Pathology Services— Cystic fibrosis gene testing) Determination 2018 to amend the descriptor of Medicare Benefits Schedule item 73348 to allow medical practitioners to request the item.
Administered by: Health
Registered 20 Nov 2019
Tabling HistoryDate
Tabled HR25-Nov-2019
Tabled Senate25-Nov-2019
To be repealed 25 Feb 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Amendment Determination 2019

I, Renaye Lucchese, delegate of the Minister for Health, make the following determination.

Dated   18 November 2019                             

 

 

 

 

Renaye Lucchese

A/g Assistant Secretary

Diagnostic Imaging and Pathology Branch

Medical Benefits Division

Health Financing Group

Department of Health

 

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1— Amendments                                                                                          2

 

 


1  Name

                        This instrument is the Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Amendment Determination 2019.

2  Commencement

(1)              Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 January 2020

 

(2)              Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                        This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4  Schedules

                        Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


 

Schedule 1— Amendments

 

Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Determination 2018

1.    Schedule 1 (item 73348, column 2)

Omit “when requested by a specialist or consultant physician who manages the treatment of the patient”.